In the last few years, several genetic SNPs in CTLA-4 and its ligand have been recognized and demonstrated to influence the intensity of T cell-mediated immunity, resulting in various autoimmune diseases, and even the occurrence of post-transplant allograft rejection [7, 8]. Here, CTLA4 is linked to autoimmune disease.